Consumption of anorexigenic amphetamine-like drugs (diethylpropion, fenproporex and mazindol) and of d,l-fenfluramine in Brazil during the years of 1988 and 1989

Pharmacoepidemiology and Drug Safety

Volumn 5, Issue 1, 1996, Pages 19-25

  Nappo, Solange A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amphetamine like drugs; Anorexigenic drugs; d,l Fenfluramine; DDS 1000 inhabitants day; Diethylpropion; Fenproporex; Mazindol; Psychostimulant drugs; Weight reducing drugs

Indexed keywords

AMFEPRAMONE; ANOREXIGENIC AGENT; FENFLURAMINE; FENPROPOREX; MAZINDOL; PSYCHOSTIMULANT AGENT;

ARTICLE; BRAZIL; CONTROLLED STUDY; DRUG COST; DRUG USE; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0029914978     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199601)5:1<19::AID-PDS191>3.0.CO;2-K     Document Type: Article

References (37)

1. INCB: International Narcotics Control Board. Chapter 2: Operation of the international drug control system. In: Report of the International Narcotics Control Board for 1989. United Nations Publication E/INCB/1989/1, New York, 1989.
2. Brooke, D., Kervin, R. and Lloyd, K. Diethylpropion hydrochloride-induced psychosis. British Journal of Psychiatry 1988; 152: 572-573.
3. Carney, M. W. P. Diethylpropion and psychosis. Clinical Neuropharmacology 1988; 11: 183-188.
4. British National Formulary. Central nervous stimulants. Ed. British Medical Association and Royal Pharmaceutical Society of Great Britain, No. 20, London, 1990.
5. Carlini, E. A. and Masur, J. Venda de medicamentos sem receita médica nas farmácias da cidade de São Paulo. Rev. Ass. Méd. Brasil 1986; 32: 75-78.
6. 15.
7. Nappo, S. A., Oliveira, E. M. and Morosini, S. A prescrição por médicos brasileiros de fórmulas magistrais para emagrecer: uma duvidosa prática para a saúde dos pacientes. Arq. bras. Med. 1994; 68: 15-20.
8. Bergman, U., Grimsson, A., Wahba, A. H. W. and Westerholm, B. Studies in Drug Utilization: Methods and Applications. WHO Regional Publications, European Series No. 8, Copenhagen, 1979.
9. Ruiz, I., Offermans, J., Fuentes, P. and Castillo, M. Utilization of benzodiazepines in Chile during 1982-1986. European Journal of Clinical Pharmacology 1989; 37: 139-143.
10. Bayer, I. Psychotropic Substances in Europe: Trends in Licit Use. International Narcotic Control Board, United Nations Publication ST/INCB/1, New York, 1990.
11. Kruk, Z. L. and Zarrindast, M. R. The effects of anorectic drugs on uptake and release of brain monoamines. British Journal of Pharmacology 1976; 58: 272P-273P.
12. Charlton, K. G. and Sugrue, M. F. Some effects of mazindol on the metabolism of monoamines in the rat brain. British Journal of Pharmacology 1976; 58: 271P.
13. Kruk, Z. L. and Zarrindast, M. R. Mazindol anorexia is mediated by activation of dopaminergic mechanisms. British Journal of Pharmacology 1976; 58: 367-372.
14. Sugrue, M. F., Shaw, G. and Charlton, K. G. Some effects of mazindol, an anorectic drug, on rat brain monoaminergic systems. European Journal of Pharmacology 1977, 42: 379-385.
15. Tognoni, G., Morselli, P. L. and Garattini, S. Amphetamine concentrations in rat brain and human urine after fenproporex administration. European Journal of Pharmacology 1972; 20: 125-126.
16. Beckett, A. H., Shenoy, E. V. B. and Salmon, J. A. The influence of replacement of the N-ethyl group by the cyanoethyl group on the absorption, distribution, and metabolism of (±)-ethylamphetamine in man. Journal of Pharm. and Pharmacology 1972; 24: 194-202.
17. Fuxe, K., Farnebo, L. O., Hamberger, B. and Ogren, S. O. On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine. Postgraduate Medical Journal 1975; 51 (Suppl. 1): 35-45.
18. Clein, L. J. and Benady, D. R. Case of diethylpropion addiction. British Medical Journal 1962; 2: 456.
19. Kuenssberg, E. V. Diethylpropion. British Medical Journal 1962; 2: 729-730.
20. Jones, H. S. Diethylpropion dependence. Medical Journal of Australia 1968; 1: 267.
21. Fookes, B. H. Schizophrenia-like reactions of diethylpropion. Lancet 1976; ii: 1206.
22. Hoffman, B. F. Diet pill psychosis. Canadian Medical Association Journal 1977; 116: 351-355.
23. Carney, M. W. P. and Harris, M. Psychiatric disorder and diethylpropion hydrochloride. The Practitioner 1979; 223: 549-552.
24. Bridgman, J. F. and Bucker, J. M. H. Drug-induced gynaecomastia. British Medical Journal 1974; 3: 520-521.
25. Hadler, A. J. Mazindol, a new non-amphetamine anorexigenic agent. Journal of Clinical Pharmacology 1972; 12: 453-458.
26. Haugen, H. N. Double blind cross-over study of a new appetite suppressant AN 448. European Journal of Clinical Pharmacology 1975; 8: 71-74.
27. Maclay, W. P. and Wallace, M. G. A multi-centre general practice trial of mazindol in the treatment of obesity. The Practitioner 1977; 218: 431-434.
28. Parkes, J. D. and Schachter, M. Mazindol in the treatment of narcolepsy. Acta Neurologica Scandinavica 1979; 60: 250-254.
29. Steel, J. M. and Briggs, M. Withdrawal depression in obese patients after fenfluramine treatment. British Medical Journal 1972; 3: 26-27.
30. Gagnon, M. A., Bordileau, J. W. and Tetreault, L. Fenfluramine: Study of its central action through the effect on sleep. International Journal of Clinical Pharmacology 1969; 1: 74-82.
31. Douglas, J. G., Munro, J. F., Kitchin, A. H., Muir, A. L. and Proudfoot, A. T. Pulmonary hypertension and fenfluramine. British Medical Journal 1981; 283: 881-883.
32. McMurrary, J., Bloomfield, P. and Miller, H. C. Irreversible pulmonary hypertension after treatment with fenfluramine. British Medical Journal 1986; 292: 239-240.
33. Levin, A. The non-medical use of fenfluramine by drug-dependent young South Africans. Postgraduate Medical Journal 1975; 51 (Suppl. 1): 186-188.
34. Dare, G. L. and Goldney, R. D. Fenfluramine abuse. Medical Journal of Australia 1976; 2: 537-540.
35. Schechter, M. D. Functional consequences of fenfluramine neurotoxicity. Pharmacology, Biochemistry and Behaviour 1990; 37: 623-626.
36. Schuster, C. R., Lewis, M. and Seiden, L. S. Fenfluramine: Neurotoxicity. Psychopharmacology Bulletin 1986; 22: 148-151.
37. Cordas, T. A., Negrão, A. B., Castilho, S. M., Segal, A., Beyruti, M. and Behar, V. S. Bulimia in the third world: why not? A Brazilian experience. Proc. 9th World Congress of Psychiatry, Rio de Janeiro, 1993, pp. 544-545.